150 related articles for article (PubMed ID: 8012955)
1. Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas.
Clark HM; Yano T; Otsuki T; Jaffe ES; Shibata D; Raffeld M
Cancer Res; 1994 Jul; 54(13):3383-6. PubMed ID: 8012955
[TBL] [Abstract][Full Text] [Related]
2. Histological progression of follicular lymphoma associated with p53 mutation and rearrangement of the C-MYC gene.
Takimoto Y; Takafuta T; Imanaka F; Kuramoto A; Sasaki N; Nanba K
Hiroshima J Med Sci; 1996 Jun; 45(2):69-73. PubMed ID: 8810134
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma.
Knowles DM
Semin Diagn Pathol; 1997 Feb; 14(1):67-82. PubMed ID: 9044511
[TBL] [Abstract][Full Text] [Related]
4. c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas.
Peng H; Diss T; Isaacson PG; Pan L
J Pathol; 1997 Apr; 181(4):381-6. PubMed ID: 9196434
[TBL] [Abstract][Full Text] [Related]
5. Detection of single and associated lesions of the Bcl-1, Bcl-2, Bcl-6, c-myc, p53 and p16 genes in B-cell non-Hodgkin's lymphomas: value of molecular analysis for a better assignment of the histologic subtype.
García-Sanz R; Vargas Montero M; Gonzalez Díaz M; del Carmen M; Santos C; Balanzategui Echevarria A; Flores Corral T; Hernández Martín JM; Caballero Barrigón MD; San Miguel JF
Haematologica; 1998 Mar; 83(3):209-16. PubMed ID: 9573674
[TBL] [Abstract][Full Text] [Related]
6. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
[TBL] [Abstract][Full Text] [Related]
7. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
Yano T; Sander CA; Clark HM; Dolezal MV; Jaffe ES; Raffeld M
Oncogene; 1993 Oct; 8(10):2741-8. PubMed ID: 8397370
[TBL] [Abstract][Full Text] [Related]
8. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the 5' noncoding region of the BCL-6 gene in primary bone lymphomas.
Gianelli U; Ponzoni M; Moro A; Alfano RM; Pellegrini C; Giardini R; Patriarca C; Armiraglio E; Bosari S; Parafioriti A; Coggi G
Ann Hematol; 2003 Nov; 82(11):691-5. PubMed ID: 14513282
[TBL] [Abstract][Full Text] [Related]
10. MYC and aggressive B-cell lymphomas.
Slack GW; Gascoyne RD
Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of MYC in common epithelial cancers and acute leukemias.
Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Jun; 114(6):436-9. PubMed ID: 16856965
[TBL] [Abstract][Full Text] [Related]
12. What is Burkitt's lymphoma?
Wright DH
J Pathol; 1997 Jun; 182(2):125-7. PubMed ID: 9274520
[TBL] [Abstract][Full Text] [Related]
13. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
14. [Diffuse large B-cell lymphoma mainly involving the heart and showing t(8;14) (q24;q32) with c-myc rearrangement].
Takai K; Sanada M; Hirose Y; Shibuya H
Rinsho Ketsueki; 1997 Sep; 38(9):757-62. PubMed ID: 9364867
[TBL] [Abstract][Full Text] [Related]
15. Emerging pathways in the development of AIDS-related lymphomas.
Carbone A
Lancet Oncol; 2003 Jan; 4(1):22-9. PubMed ID: 12517536
[TBL] [Abstract][Full Text] [Related]
16. Common and HIV-related diffuse large B-cell lymphomas differ in their immunoglobulin gene mutation pattern.
Delecluse HJ; Hummel M; Marafioti T; Anagnostopoulos I; Stein H
J Pathol; 1999 Jun; 188(2):133-8. PubMed ID: 10398155
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
Gaidano G; Pastore C; Volpe G
Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
[TBL] [Abstract][Full Text] [Related]
18. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
[TBL] [Abstract][Full Text] [Related]
19. Somatic hypermutation and B-cell lymphoma.
Dunn-Walters D; Thiede C; Alpen B; Spencer J
Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
[TBL] [Abstract][Full Text] [Related]
20. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
